consists of antisense oligonucleotide, or ASO. It is a targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, ...
There’s a good reason why precision medicine sparks such excitement and controversy. It promises individualized diagnosis and targeted therapy that can treat the most challenging and incurable of diseases — yet the numerous obstacles standing in its way, such as regulatory approvals and affordability...
- Chief, Division of Infectious Disease, John Hopkins University School of Medicine• Carlos T. Moraes, Ph.D. - Lichtenstein Professor for Neurology, University of Miami Miller School of Medicine • Michio Hirano, M.D. - Chief, Division of Neuromuscular Disorders, New York Presbyterian/...
System, which combines PCR and capillary electrophoresis to provide multiplexed, quantitative clinical solutions. PrimeraDX primarily serves the oncology, infectious disease, translational medicine research, and pharmaceutical quality control sectors. It was founded in 2004 and is based in Mansfield, ...
Image: © [M] sdecoret / Stock.adobe.com Open for submissions Collection|27 March 2024 Natural language processing in Clinical Medicine This Collection welcomes research on Natural Language Processing innovations to improving medical and population health outcomes, with a particular emphasis on computa...
In the last three decades, a cohort of genomicists have intentionally sought to include more racially diverse people in their research in human genomics and precision medicine. How such efforts to be inclusive in human genomic research and precision medi
Additionally, NPM Phase II will enhance the breadth and depth of the Precision Medicine-related industry by attracting and anchoring overseas companies in Singapore, while yielding new opportunities for home-grown companies. To enhance and accelerate the precision medicine sector, PRECISE works in close...
The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating...
Phil Johnson, MD, CEO of Interius BioTherapeutics, toldInside Precision Medicine, “The simplicity of this is that you simply call the pharmacy, they send a vial down, and the vector gets infused directly into the patient. The patient can go home. The other part of this ...
Large variability in the individual response to even the most-efficacious pain treatments is observed clinically, which has led to calls for a more personalized, tailored approach to treating patients with pain (ie, “precision pain medicine”). Precision pain medicine, currently an aspirational goal...